Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Mayinglong Pharmaceutical Group Co Ltd
Operating Expenses
Mayinglong Pharmaceutical Group Co Ltd
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
|
Operating Expenses
-¥995.9m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Expenses
-¥5.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Expenses
-¥1.2B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-18%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Expenses
-¥15B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-16%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Expenses
-¥6.7B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-10%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Operating Expenses
-¥346.3m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
See Also
What is Mayinglong Pharmaceutical Group Co Ltd's Operating Expenses?
Operating Expenses
-995.9m
CNY
Based on the financial report for Sep 30, 2023, Mayinglong Pharmaceutical Group Co Ltd's Operating Expenses amounts to -995.9m CNY.
What is Mayinglong Pharmaceutical Group Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-8%
Over the last year, the Operating Expenses growth was -13%. The average annual Operating Expenses growth rates for Mayinglong Pharmaceutical Group Co Ltd have been -13% over the past three years , -9% over the past five years , and -8% over the past ten years .